Molecular determinants of tissue selectivity in estrogen receptor modulators

Timothy A. Grese1, James P. Sluka1, Henry U. Bryant1, George J. Cullinan1, Andrew L. Glasebrook1, Charles D. Jones1, Ken Matsumoto1, Alan D. Palkowitz1, Masahiko Sato1, John D. Termine1, Mark A. Winter1, Na Yang1, Jeffrey A. Dodge1
1Endocrine Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285

Tóm tắt

Interaction of the estrogen receptor/ligand complex with a DNA estrogen response element is known to regulate gene transcription. In turn, specific conformations of the receptor-ligand complex have been postulated to influence unique subsets of estrogen-responsive genes resulting in differential modulation and, ultimately, tissue-selective outcomes. The estrogen receptor ligands raloxifene and tamoxifen have demonstrated such tissue-specific estrogen agonist/antagonist effects. Both agents antagonize the effects of estrogen on mammary tissue while mimicking the actions of estrogen on bone. However, tamoxifen induces significant stimulation of uterine tissue whereas raloxifene does not. We postulate that structural differences between raloxifene and tamoxifen may influence the conformations of their respective receptor/ligand complexes, thereby affecting which estrogen-responsive genes are modulated in various tissues. These structural differences are 4-fold: ( A ) the presence of phenolic hydroxyls, ( B ) different substituents on the basic amine, ( C ) incorporation of the stilbene moiety into a cyclic benzothiophene framework, and ( D ) the imposition of a carbonyl “hinge” between the basic amine-containing side chain and the olefin. A series of raloxifene analogs that separately exemplify each of these differences have been prepared and evaluated in a series of in vitro and in vivo assays. This strategy has resulted in the development of a pharmacophore model that attributes the differences in effects on the uterus between raloxifene and tamoxifen to a low-energy conformational preference imparting an orthogonal orientation of the basic side chain with respect to the stilbene plane. This three-dimensional array is dictated by a single carbon atom in the hinge region of raloxifene. These data indicate that differences in tissue selective actions among benzothiophene and triarylethylene estrogen receptor modulators can be ascribed to discrete ligand conformations.

Từ khóa


Tài liệu tham khảo

J A Katzenellenbogen, B W O’Malley, B S Katzenellenbogen Mol Endocrinol 10, 119–131 (1996).

10.1016/S1074-5521(96)90143-X

10.1021/jm00025a001

10.1002/j.1552-4604.1993.tb03916.x

10.1002/j.1460-2075.1990.tb07469.x

M T Tzukerman, A Esty, D Santiso-Mere, P Danielian, M G Parker, R B Stein, J W Pike, D P McDonnell Mol Endocrinol 8, 21–30 (1994).

P Webb, G N Lopez, R M Uht, P J Kushner Mol Endocrinol 9, 443–456 (1995).

10.1126/science.273.5279.1222

D P McDonnell, D L Clemm, T Hermann, M E Goldman, J W Pike Mol Endocrinol 9, 659–669 (1995).

J M Beekman, G F Allan, S Y Tsai, M-J Tsai, B W O’Malley Mol Endocrinol 7, 1266–1274 (1993).

10.1016/0039-128X(95)00219-G

10.1111/j.1749-6632.1995.tb31374.x

10.1016/0960-0760(95)00137-O

10.1016/0960-894X(96)00141-2

10.1073/pnas.93.12.5925

10.1016/0014-5793(96)00782-X

T A Grese, J A Dodge Annu Rep Med Chem 31, 181–190, , and references therein. (1996).

10.1016/0022-4731(88)90014-3

10.1096/fasebj.10.8.8666168

10.1016/S0140-6736(94)92466-X

10.1172/JCI116985

10.1002/jbmr.5650110615

10.1021/jm9606352

10.1021/jm00374a021

10.1021/jo00108a046

10.1021/jm00294a011

10.1016/S0960-894X(96)00502-1

10.1021/jo00910a002

10.1016/S0960-0760(96)00104-5

M Sato, J Kim, L L Short, C W Slemanda, H U Bryant J Pharmacol Exp Ther 272, 1252–1259 (1995).

10.1021/jm970167b

J P Stewart Quantum Chemistry Program Exchange (Indiana University, Bloomington, IN, , Program No. 455, version 6.0 and references therein. (1990).

10.1677/joe.0.0750305

10.1021/jm00344a015

10.1016/S0039-128X(96)00242-5

10.1016/0022-4731(88)90005-2